Global Leprosy Treatment Market Report By Drug Class Type (Antibacterial, Leprostatics, Antitubercular, Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Leprosy Treatment Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11213312

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Leprosy Treatment Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Leprosy treatment is a multidrug therapy used to treat the chronic and progressive bacterial infection leprosy, also called Hansen’s disease. Leprosy is characterized by symptoms like skin ulcers, nerve damage, and muscle weakness leading to severe disfigurement and significant disability. A skin biopsy diagnoses the different types of leprosy. The treatment involves a multidrug therapy (MDT) with a combination of drugs like rifampicin, dapsone, clofazimine, and minocycline for a period ranging from six months to two years, based on the type of the disease and its clinical severity. Early diagnosis and full anti-microbial courses and prompt treatment of leprosy reactions make a complete cure possible in almost every case of leprosy. The therapy involves minor side effects that can cause social and emotional distress.

Market Dynamics

The expanding pool of the global population suffering from leprosy and the availability of new treatment options will be the major driving forces for this market’s growth. Raising awareness through campaigns, improved diagnosis, and the emergence of new technologies will further propel market growth. The increased initiatives by government organizations, availability of reimbursement policies for high-cost MDT therapies will be a market booster. Improving healthcare systems and medical facilities will be a boon to the market growth. The major roadblocks to this market’s growth are low healthcare penetration and inefficient diagnosis due to poor socio-economic conditions.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of leprosy treatment.

Market Segmentation

The entire leprosy treatment market has been sub-categorized into drug class type, route of administration and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Drug Class Type

Antibacterial
Leprostatics
Antitubercular
Others

By Route of Administration

Oral
Injectable
Topical

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for leprosy treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Leprosy Treatment Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the leprosy treatment market include Pfizer Inc., Bristol-Myers Squibb and Company, Eli Lily and Company, Johnson & Johnson Services Inc., GlaxoSmithKline PLC, Bayer AG, Cadila Pharmaceuticals, Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals, Merck & Co., Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Leprosy Treatment Market
       2.2. Global Leprosy Treatment Market Snapshot

3 . LEPROSY TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Leprosy Treatment Market
       3.3. Market Restraints of Leprosy Treatment Market
       3.4. Opportunities of Leprosy Treatment Market
       3.5. Trends of Leprosy Treatment Market
       3.6. Porter’s Five Force Analysis of Leprosy Treatment Market
       3.7. Leprosy Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drug Class Type
           3.7.2 Market Attractive Analysis by Route of Administration
           3.7.3 Market Attractive Analysis by Distribution Channel
           3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Leprosy Treatment Value Chain Analysis
       4.2. Leprosy Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Leprosy Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Leprosy Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Leprosy Treatment Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Leprosy Treatment Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Leprosy Treatment Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Leprosy Treatment Market

6 . GLOBAL LEPROSY TREATMENT MARKET ANALYSIS BY DRUG CLASS TYPE
       6.1 Overview by Drug Class Type
       6.2 Historical Data 2015-2018
       6.3 Global Leprosy Treatment Market Analysis by Drug Class Type
       6.4 Market Analysis of Antibacterial by Regions
       6.6 Market Analysis of Leprostatics by Regions
       6.5 Market Analysis of Antitubercular by Regions
       6.7 Market Analysis of Others by Regions

7 . GLOBAL LEPROSY TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
       7.1 Overview by Route of Administration
       7.2 Historical Data 2015-2018
       7.3 Global Leprosy Treatment Market Analysis by Route of Administration
       7.4 Market Analysis of Oral by Regions
       7.5 Market Analysis of Injectable by Regions
       7.6 Market Analysis of Topical by Regions

8 . GLOBAL LEPROSY TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       8.1 Overview by Distribution Channel
       8.2 Historical Data 2015-2018
       8.3 Global Leprosy Treatment Market Analysis by Distribution Channel
       8.4 Market Analysis of Hospital Pharmacies by Regions
       8.5 Market Analysis of Retail Pharmacies by Regions
       8.6 Market Analysis of Drug Stores by Regions
       8.7 Market Analysis of Online Pharmacies by Regions

9 . GLOBAL LEPROSY TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview and Historic Data
           9.3.2. North America Leprosy Treatment Market Estimate By Market Segment
           9.3.3. North America Leprosy Treatment Market Estimate By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview and Historic Data
           9.4.2. Europe Leprosy Treatment Market Estimate by Market Segment
           9.4.3. Europe Leprosy Treatment Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview and Historic Data
           9.5.2. Asia Pacific Leprosy Treatment Market Estimate by Market Segment
           9.5.3. Asia Pacific Leprosy Treatment Market Estimate by Country
           9.5.4. China
         9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview and Historic Data
           9.6.2. Latin America Leprosy Treatment Market Estimate by Market Segment
           9.6.3. Latin America Leprosy Treatment Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview and Historic Data
           9.7.2. Middle East & Africa Leprosy Treatment Market Estimate by Market Segment
           9.7.3. Middle East & Africa Leprosy Treatment Market Estimate by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE LEPROSY TREATMENT COMPANIES
       10.1. Leprosy Treatment Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments

11 . COMPANY PROFILES OF LEPROSY TREATMENT INDUSTRY
     11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Pfizer Inc.
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Bristol-Myers Squibb and Company
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Eli Lily and Company
           11.5.1. Company Overview
           11.5.2. Financials
         11.5.3. Products
           11.5.4. Recent Developments
       11.6. Johnson & Johnson Services Inc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. GlaxoSmithKline PLC
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Bayer AG
           11.8.1. Company Overview
           11.8.2. Financials
         11.8.3. Products
           11.8.4. Recent Developments
       11.9. Cadila Pharmaceuticals
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Sanofi S.A.
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Novartis AG
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Teva Pharmaceutical Industries Ltd.
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. Macleods Pharmaceuticals
           11.13.1. Company Overview
           11.13.2. Financials
           11.13.3. Products
           11.13.4. Recent Developments
       11.14. Merck & Co., Inc.
           11.14.1. Company Overview
           11.14.2. Financials
           11.14.3. Products
           11.14.4. Recent Developments

*Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Leprosy Treatment Report
Market Research Process
Market Research Methodology
Global Leprosy Treatment Market Size, by Region (2019)
Porters Five Forces Analysis
Market Attractiveness Analysis by Drug Class Type
Market Attractiveness Analysis by Route of Administration
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Leprosy Treatment Market Analysis by Drug Class Type
Global Leprosy Treatment Market Analysis in Antibacterial by Region
Global Leprosy Treatment Market Analysis in Leprostatics by Region
Global Leprosy Treatment Market Analysis in Antitubercular by Region
Global Leprosy Treatment Market Analysis in Others by Region
Global Leprosy Treatment Market Analysis by Route of Administration
Global Leprosy Treatment Market Analysis in Oral by Region
Global Leprosy Treatment Market Analysis in Injectable by Region
Global Leprosy Treatment Market Analysis in Topical by Region
Global Leprosy Treatment Market Analysis by Distribution Channel
Global Leprosy Treatment Market Analysis in Hospital Pharmacies by Region
Global Leprosy Treatment Market Analysis in Retail Pharmacies by Region
Global Leprosy Treatment Market Analysis in Drug Stores by Region
Global Leprosy Treatment Market Analysis in Online Pharmacies by Region
Global Leprosy Treatment Market by Revenue
North America Leprosy Treatment Market by Revenue
Europe Leprosy Treatment Market by Revenue
Asia Pacific Leprosy Treatment Market by Revenue
Latin America Leprosy Treatment Market by Revenue
Middle East & Africa Leprosy Treatment Market by Revenue
Recent Development in Leprosy Treatment Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "